Cargando…

Loss of DARPP-32 and calbindin in multiple system atrophy

We evaluated the immunohistochemical intensities of α-synuclein, phosphorylated α-synuclein (p-syn), dopamine- and cAMP-regulated phosphoprotein of 32 kDa (DARPP-32), calbindin-D 28k, calpain-cleaved carboxy-terminal 150-kDa spectrin fragment, and tyrosine hydroxylase in multiple system atrophy (MSA...

Descripción completa

Detalles Bibliográficos
Autores principales: Hayakawa, Hideki, Nagai, Makiko, Kawanami, Aya, Nakata, Yasuto, Nihira, Tomoko, Ogino, Mieko, Takada, Masahiko, Saido, Takaomi, Takano, Jiro, Saegusa, Makoto, Mikami, Tetsuo, Hamada, Junichi, Nishiyama, Kazutoshi, Mochizuki, Hideki, Mizuno, Yoshikuni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3834182/
https://www.ncbi.nlm.nih.gov/pubmed/23715974
http://dx.doi.org/10.1007/s00702-013-1039-4
_version_ 1782291943286374400
author Hayakawa, Hideki
Nagai, Makiko
Kawanami, Aya
Nakata, Yasuto
Nihira, Tomoko
Ogino, Mieko
Takada, Masahiko
Saido, Takaomi
Takano, Jiro
Saegusa, Makoto
Mikami, Tetsuo
Hamada, Junichi
Nishiyama, Kazutoshi
Mochizuki, Hideki
Mizuno, Yoshikuni
author_facet Hayakawa, Hideki
Nagai, Makiko
Kawanami, Aya
Nakata, Yasuto
Nihira, Tomoko
Ogino, Mieko
Takada, Masahiko
Saido, Takaomi
Takano, Jiro
Saegusa, Makoto
Mikami, Tetsuo
Hamada, Junichi
Nishiyama, Kazutoshi
Mochizuki, Hideki
Mizuno, Yoshikuni
author_sort Hayakawa, Hideki
collection PubMed
description We evaluated the immunohistochemical intensities of α-synuclein, phosphorylated α-synuclein (p-syn), dopamine- and cAMP-regulated phosphoprotein of 32 kDa (DARPP-32), calbindin-D 28k, calpain-cleaved carboxy-terminal 150-kDa spectrin fragment, and tyrosine hydroxylase in multiple system atrophy (MSA). The caudate head, anterior putamen, posterior putamen, substantia nigra, pontine nucleus, and cerebellar cortex from six MSA brains, six age-matched disease control brains (amyotrophic lateral sclerosis), and five control brains were processed for immunostaining by standard methods. Immunostaining for α-synuclein, p-syn, or both was increased in all areas examined in oligodendrocytes in MSA. Immunostaining for DARPP-32 and calbindin-D 28k was most prominently decreased in the posterior putamen, where neuronal loss was most prominent. Immunostaining for DARPP-32 and calbindin-D 28k was also diminished in the anterior putamen and caudate head, where neuronal loss was less prominent or absent. Calbindin immunostaining was also decreased in the dorsal tier of the substantia nigra and cerebellar cortex. Loss of immunostaining for DARPP-32 and calbindin-D 28k compared with that of neurons indicates calcium toxicity and disturbance of the phosphorylated state of proteins as relatively early events in the pathogenesis of MSA.
format Online
Article
Text
id pubmed-3834182
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Springer Vienna
record_format MEDLINE/PubMed
spelling pubmed-38341822013-11-29 Loss of DARPP-32 and calbindin in multiple system atrophy Hayakawa, Hideki Nagai, Makiko Kawanami, Aya Nakata, Yasuto Nihira, Tomoko Ogino, Mieko Takada, Masahiko Saido, Takaomi Takano, Jiro Saegusa, Makoto Mikami, Tetsuo Hamada, Junichi Nishiyama, Kazutoshi Mochizuki, Hideki Mizuno, Yoshikuni J Neural Transm (Vienna) Neurology and Preclinical Neurological Studies - Original Article We evaluated the immunohistochemical intensities of α-synuclein, phosphorylated α-synuclein (p-syn), dopamine- and cAMP-regulated phosphoprotein of 32 kDa (DARPP-32), calbindin-D 28k, calpain-cleaved carboxy-terminal 150-kDa spectrin fragment, and tyrosine hydroxylase in multiple system atrophy (MSA). The caudate head, anterior putamen, posterior putamen, substantia nigra, pontine nucleus, and cerebellar cortex from six MSA brains, six age-matched disease control brains (amyotrophic lateral sclerosis), and five control brains were processed for immunostaining by standard methods. Immunostaining for α-synuclein, p-syn, or both was increased in all areas examined in oligodendrocytes in MSA. Immunostaining for DARPP-32 and calbindin-D 28k was most prominently decreased in the posterior putamen, where neuronal loss was most prominent. Immunostaining for DARPP-32 and calbindin-D 28k was also diminished in the anterior putamen and caudate head, where neuronal loss was less prominent or absent. Calbindin immunostaining was also decreased in the dorsal tier of the substantia nigra and cerebellar cortex. Loss of immunostaining for DARPP-32 and calbindin-D 28k compared with that of neurons indicates calcium toxicity and disturbance of the phosphorylated state of proteins as relatively early events in the pathogenesis of MSA. Springer Vienna 2013-05-29 2013 /pmc/articles/PMC3834182/ /pubmed/23715974 http://dx.doi.org/10.1007/s00702-013-1039-4 Text en © The Author(s) 2013 https://creativecommons.org/licenses/by/2.0/ Open AccessThis article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
spellingShingle Neurology and Preclinical Neurological Studies - Original Article
Hayakawa, Hideki
Nagai, Makiko
Kawanami, Aya
Nakata, Yasuto
Nihira, Tomoko
Ogino, Mieko
Takada, Masahiko
Saido, Takaomi
Takano, Jiro
Saegusa, Makoto
Mikami, Tetsuo
Hamada, Junichi
Nishiyama, Kazutoshi
Mochizuki, Hideki
Mizuno, Yoshikuni
Loss of DARPP-32 and calbindin in multiple system atrophy
title Loss of DARPP-32 and calbindin in multiple system atrophy
title_full Loss of DARPP-32 and calbindin in multiple system atrophy
title_fullStr Loss of DARPP-32 and calbindin in multiple system atrophy
title_full_unstemmed Loss of DARPP-32 and calbindin in multiple system atrophy
title_short Loss of DARPP-32 and calbindin in multiple system atrophy
title_sort loss of darpp-32 and calbindin in multiple system atrophy
topic Neurology and Preclinical Neurological Studies - Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3834182/
https://www.ncbi.nlm.nih.gov/pubmed/23715974
http://dx.doi.org/10.1007/s00702-013-1039-4
work_keys_str_mv AT hayakawahideki lossofdarpp32andcalbindininmultiplesystematrophy
AT nagaimakiko lossofdarpp32andcalbindininmultiplesystematrophy
AT kawanamiaya lossofdarpp32andcalbindininmultiplesystematrophy
AT nakatayasuto lossofdarpp32andcalbindininmultiplesystematrophy
AT nihiratomoko lossofdarpp32andcalbindininmultiplesystematrophy
AT oginomieko lossofdarpp32andcalbindininmultiplesystematrophy
AT takadamasahiko lossofdarpp32andcalbindininmultiplesystematrophy
AT saidotakaomi lossofdarpp32andcalbindininmultiplesystematrophy
AT takanojiro lossofdarpp32andcalbindininmultiplesystematrophy
AT saegusamakoto lossofdarpp32andcalbindininmultiplesystematrophy
AT mikamitetsuo lossofdarpp32andcalbindininmultiplesystematrophy
AT hamadajunichi lossofdarpp32andcalbindininmultiplesystematrophy
AT nishiyamakazutoshi lossofdarpp32andcalbindininmultiplesystematrophy
AT mochizukihideki lossofdarpp32andcalbindininmultiplesystematrophy
AT mizunoyoshikuni lossofdarpp32andcalbindininmultiplesystematrophy